Skip to main content
. 2021 Jan 26;30:102576. doi: 10.1016/j.nicl.2021.102576

Table 1.

Demographic data and clinical assessment results in PDM and CON groups.

PDM (n = 115) CON (n = 117) p-value
Main effect
Interaction
Group Genotype
Age, y/o 23.5 (2.2) 24.1 (2.5) 0.03* 0.13 0.10
Val/Val 22.8 (1.9) 24.2 (2.7)
Val/Met 24.2 (2.5) 24.1 (2.6)
Met/Met 23.1 (1.7) 24.0 (2.4)
Age of menarche, y/o 12.1 (1.2) 12.2 (1.2) 0.44 0.88 0.82
Val/Val 12.1 (1.3) 12.1 (1.3)
Val/Met 12.0 (1.2) 12.3 (1.1)
Met/Met 12.2 (1.1) 12.3 (1.3)
Gynecological age, years 11.4 (2.5) 11.8 (2.7) 0.12 0.18 0.08
Val/Val 10.7 (2.4) 12.0 (2.7)
Val/Met 12.2 (2.9) 11.8 (2.7)
Met/Met 10.9 (1.9) 11.7 (3.0)
Menstrual cycle, days 29.5 (1.5) 29.7 (1.5) 0.32 0.57 0.82
Val/Val 29.4 (1.6) 29.5 (1.0)
Val/Met 29.5 (1.4) 29.7 (1.7)
Met/Met 29.5 (1.4) 29.9 (1.5)
Estradiol (pg/mL) 139.7 (100.4) 125.5 (106.7) 0.33 0.07 0.70
Val/Val 106.8 (75.5) 104.4 (95.7)
Val/Met 145.8 (101.9) 138.2 (117.5)
Met/Met 157.4 (111.5) 125.5 (94.1)
Age of onset, y/o 15.1 (2.2) 0.12
Val/Val 15.8 (2.0)
Val/Met 14.9 (2.2)
Met/Met 14.8 (2.2)
Pain history, years 8.3 (3.1) 0.004*
Val/Val 7.0 (2.8)
Val/Met 9.3 (3.5)
Met/Met 8.2 (2.2)
Pain duration, days 1.8 (0.8) 0.12
Val/Val 1.8 (0.8)
Val/Met 1.7 (0.8)
Met/Met 2.0 (0.8)
Recall numeric pain rating scale 6.9 (1.5) 0.93
Val/Val 6.8 (1.7)
Val/Met 6.9 (1.5)
Met/Met 6.9 (1.3)
MPQ-recalled pain rating scale 35.4 (13.9) 0.70
Val/Val 33.5 (14.6)
Val/Met 35.8 (13.9)
Met/Met 36.2 (13.6)

Data are expressed as mean (standard deviation) and *, p < 0.05.

Abbreviations: PDM, primary dysmenorrhea; CON, control; BDNF, brain-derived neurotrophic factor; Val, Valine; Met, Methionine; MPQ, McGill Pain Questionnaire.